StockData
Globe Life Inc. logo

Globe Life Inc. (GL) stock analysis

GLNYSELife InsuranceFiscal year ends December 31Also trades as GL.PD
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/302% above fair value
$161.80−1.66 (-1.02%)

Close on Nov 11, 2026Market cap $12.43BP/E 10.8Yield 0.67%

StockData Score

Prices as of Nov 11, 2026How the score works

Value0Growth2Performance6Health1Dividend4

Mixed13 of 30 checks passed

Globe Life passes 13 of the 30 checks behind our score; 4 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
0/6
Growth
2/6
Past performance
6/6
Financial health
1/6
Dividend
4/6

What stands out

  • Return on equity over 15%

    Return on equity was 19.3% over the last twelve months and averaged 22.9% over five years.

  • Earnings grew over 5 years

    Net income grew 9.7% a year on average over the last five fiscal years.

  • EPS growing 10%+ a year

    Diluted EPS grew 15.9% a year over the last three fiscal years.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 47.3% of total debt.

What to watch

  • Margin of safety under 20%

    The price is 1.7% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $161.80 is above our fair value estimate of $159.06.

  • High debt

    Debt is 45.1% of shareholders' equity, above the 40% we consider low.

  • Revenue growing under 10% a year

    Revenue grew 4.7% a year over the last three fiscal years, short of the 10% we look for.

Valuation0/6
  • P/E above its 5-year median

    Globe Life's P/E of 10.8 is above its own 5-year median of 10.5.

  • P/E above the industry

    Globe Life's P/E of 10.8 is above the Life Insurance median of 10.8.

  • P/S above the industry

    Globe Life's price-to-sales of 1.98 is above the Life Insurance median of 0.67.

  • P/B above the industry

    Globe Life's price-to-book of 1.88 is above the Life Insurance median of 1.11.

  • Trading above fair value

    The share price of $161.80 is above our fair value estimate of $159.06.

  • Margin of safety under 20%

    The price is 1.7% above fair value, so there is no margin of safety.

Growth2/6
  • Revenue growing under 10% a year

    Revenue grew 4.7% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing 10%+ a year

    Diluted EPS grew 15.9% a year over the last three fiscal years.

  • Earnings growth not accelerating

    Net income grew 3.1% over the last twelve months, against a 5-year average of 9.7% a year.

  • Growing slower than the industry

    Revenue grew 5.6% over the last twelve months; the Life Insurance median is 7.1%.

  • Guidance raised

    Globe Life raised its full-year 2026 earnings guidance outlook on Jul 22, 2026.

  • Gross margin trend

    Banks and insurers do not report gross profit.

Past performance6/6
  • Return on equity over 15%

    Return on equity was 19.3% over the last twelve months and averaged 22.9% over five years.

  • Return on assets over 1%

    Return on assets was 3.9%; for a bank or insurer, 1% or more is considered good.

  • Return on equity above the industry

    Globe Life's return on equity of 19.3% is above the Life Insurance median of 12.6%.

  • Earnings grew over 5 years

    Net income grew 9.7% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 18.9% over the last twelve months, against a 5-year average of 18.6%.

  • Net margin above the industry

    Globe Life's net margin of 18.9% is above the Life Insurance median of 8.1%.

Financial health1/6
  • High debt

    Debt is 45.1% of shareholders' equity, above the 40% we consider low.

  • Debt rising against equity

    Debt to equity rose from 21.9% five years ago to 45.1%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 47.3% of total debt.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term liquidity

    Insurers do not split assets into current and non-current.

  • Bankruptcy risk (Altman Z)

    The Altman model does not apply to insurers.

Dividend4/6
  • Pays a dividend

    Globe Life paid dividends worth 0.8% of the share price over the last twelve months.

  • Yield below Treasuries

    The 0.8% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Globe Life yields 0.8%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.

  • Covered by earnings

    Dividends take 7.9% of net income.

  • Covered by free cash flow

    Dividends take 7.1% of free cash flow.

Scores of similar companies

Our estimate per share

$159.06

The share price is 2% above this estimate.

20%+ below
Near fair value
20%+ above
$161.80Price
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E10.7×10.5×10.8×$159.5650%
P/B1.8×2.6×1.1×$158.5650%
Fair value$159.06100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 10.5
  • Life Insurance median 10.8

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$93.46M
Value traded per 1% price move
$84.59M

Downside

Low risk

Typical loss in a bad month
6.5%
Volatility (annualized)
21%
Sharpe ratio, 1 year
0.82
Beta to the S&P 500 (5Y)
0.55

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

–

Operating margin

–

Net margin

19.4%+3.9 pts over 5 years

See a number that looks wrong?